search
Back to results

Endometrial Gene Expression Profile in Controlled Ovarian Stimulation Cycles With Premature Luteinization

Primary Purpose

Premature Luteinization

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
endometrial biopsy
Sponsored by
Instituto Valenciano de Infertilidad, IVI VALENCIA
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional trial for Premature Luteinization

Eligibility Criteria

18 Years - 35 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Oocyte donors
  • Age between 18-35 years old
  • BMI 18-29
  • NORMOGONADOTROPHICS
  • PROGESTERONE ≥ 1.2 ng/ml on hCG day

Exclusion Criteria:

  • PolyCystic Ovarian Syndrome (PCOS)
  • Endometriosis

Sites / Locations

  • Ivi Valencia

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
March 13, 2007
Last Updated
September 18, 2009
Sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA
search

1. Study Identification

Unique Protocol Identification Number
NCT00447850
Brief Title
Endometrial Gene Expression Profile in Controlled Ovarian Stimulation Cycles With Premature Luteinization
Official Title
Endometrial Gene Expression Profile in Controlled Ovarian Stimulation Cycles With Premature Luteinization
Study Type
Interventional

2. Study Status

Record Verification Date
September 2009
Overall Recruitment Status
Completed
Study Start Date
April 2007 (undefined)
Primary Completion Date
July 2009 (Actual)
Study Completion Date
July 2009 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA

4. Oversight

5. Study Description

Brief Summary
Previous studies have suggested that premature luteinization (PL)during controlled ovarian stimulation (COS) decreases the implantation rate due to a negative effect on the endometrium receptivity. This study aims to describe the impact on endometrial gene expression of PL in GnRH antagonist and GnRH agonist cycles.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Premature Luteinization

7. Study Design

Study Phase
Not Applicable

8. Arms, Groups, and Interventions

Intervention Type
Procedure
Intervention Name(s)
endometrial biopsy

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Oocyte donors Age between 18-35 years old BMI 18-29 NORMOGONADOTROPHICS PROGESTERONE ≥ 1.2 ng/ml on hCG day Exclusion Criteria: PolyCystic Ovarian Syndrome (PCOS) Endometriosis
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elena Labarta, MD
Organizational Affiliation
Instituto Valenciano de la Infertilidad
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ivi Valencia
City
Valencia
ZIP/Postal Code
46015
Country
Spain

12. IPD Sharing Statement

Learn more about this trial

Endometrial Gene Expression Profile in Controlled Ovarian Stimulation Cycles With Premature Luteinization

We'll reach out to this number within 24 hrs